Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Allergan plc (NYSE: AGN).

Full DD Report for AGN

You must become a subscriber to view this report.


Recent News from (NYSE: AGN)

Allergan plc (AGN) CEO Brenton Saunders Presents at Citi Global Healthcare Conference (Transcript)
Allergan plc (AGN) Citi Global Healthcare Conference (Transcript) December 6, 2018, 11:00 AM ET Executives Brenton Saunders - Chairman, President and Chief Executive Officer Analysts Liav Abraham - Citigroup Presentation Liav Abraham Thank you, everyone. My name is Li...
Source: SeekingAlpha
Date: December, 06 2018 15:24
THW: Global Healthcare Fund With 10%+ Yield
Tekla World Healthcare Fund ( THW ) is quite similar to another fund I just recently covered , Tekla Healthcare Opportunities Fund ( THQ ). Both funds focused on the healthcare sector. Actually, the four funds Tekla offers all cover healthcare related sectors. I believe THW is at a level offe...
Source: SeekingAlpha
Date: December, 06 2018 13:45
Biohaven Pharma up 17% on positive data on migraine med Zydis
Thinly traded Biohaven Pharmaceutical Holding Company ( BHVN +17.1% ) is up on more than double normal volume following its announcement of topline data from a Phase 3 clinical trial, BHV3000-303 , evaluating lead candidate Zydis (rimegepant) orally dissolving tablet for the acute treat...
Source: SeekingAlpha
Date: December, 03 2018 12:05
Healthcare Yields Of 3% To 4.8% From Top 10 WallStars In November
Actionable Conclusions (1-10): Analysts Projected 14.7% To 40.7% Net Gains For Top Ten Healthcare WallStars By November 2019 Five of ten top dividend-yielding Healthcare stocks were verified as being among the top ten gainers for the coming year based on broker 1-year target prices. ...
Source: SeekingAlpha
Date: November, 30 2018 11:58
Recent Analysis Shows Applied Optoelectronics, J.M. Smucker, RYB Education, Inc. Sponsored ADR, Workiva, Bilibili Inc. Sponsored ADR, and Allergan plc Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Applied Optoelectronics, Inc. (NASDAQ:AAOI), The J.M. Smucker Company ...
Source: GlobeNewswire
Date: November, 30 2018 08:20
FDA signs off on Editas Medicine's IND for gene-editing candidate for LCA10
The FDA has approved Editas Medicine's (NASDAQ: EDIT ) Investigational New Drug (IND) application seeking signoff for clinical studies evaluating genome-editing candidate EDIT-101 for the potential treatment of Leber Congenital Amaurosis type 10 (LCA10), a group of inherited retinal disord...
Source: SeekingAlpha
Date: November, 30 2018 07:47
Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q3 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to Wallace Weitz’s 13F portfolio on a quarterly basis. It is based on Weitz’s regulatory 13F Form filed on 11/13/2018. Please visit our Tracking Wallace Weitz’s Weitz Investment Man...
Source: SeekingAlpha
Date: November, 28 2018 03:24
Allergan Makes New Appointments to Finance Leadership Team
DUBLIN , Nov. 26, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Daphne Karydas will take on the new role of Senior Vice President Corporate Financial Planning & Analysis and Strategy, and Manisha Narasimhan , Ph...
Source: PR Newswire
Date: November, 26 2018 07:30
Viking Therapeutics Won't Live Up To The Hype
NASH – an introduction Fatty deposits and mild fibrosis in non-alcoholic fatty liver disease. Source NASH – short for non-alcoholic steatohepatitis – has been a magnet for biotech investors over the past few years. NASH designates the most severe form of non-alc...
Source: SeekingAlpha
Date: November, 26 2018 05:00
What Is Bausch Health Companies Stock Worth?
After shares of Bausch Health Companies ( BHC ) touched close to the $28 level on three occasions since June, the stock continues to spend most of its time in the $22-$24 level. And yet in the third quarter, the company demonstrated that its turnaround is firmly playing out. Chances are good...
Source: SeekingAlpha
Date: November, 25 2018 11:47

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-18154.59160.23160.36154.2933,492,604
2018-05-17154.59160.23160.36154.2933,492,504
2017-11-08173.00175.01175.35173.002,917,074
2017-11-07175.00172.97175.34172.694,257,803
2017-11-06175.00174.34177.61173.984,057,996

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-077,96457,21413.9197Cover
2018-12-0614,61866,50121.9816Cover
2018-12-0411,93549,82023.9562Cover
2018-12-0316,28149,92432.6116Cover
2018-11-3012,002126,0269.5234Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AGN.


About Allergan plc (NYSE: AGN)

Logo for Allergan plc (NYSE: AGN)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $52,103,907,561 - 05/11/2018
  • Issue and Outstanding: 339,063,627 - 04/27/2018

 


Recent Filings from (NYSE: AGN)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 16 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 09 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 06 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 23 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 23 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: March, 13 2018
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Filing Type: 25-NSEFiling Source: edgar
Filing Date: March, 01 2018

 

 


Daily Technical Chart for (NYSE: AGN)

Daily Technical Chart for (NYSE: AGN)


Stay tuned for daily updates and more on (NYSE: AGN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: AGN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AGN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AGN and does not buy, sell, or trade any shares of AGN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/